1. Home
  2. OGN vs PGNY Comparison

OGN vs PGNY Comparison

Compare OGN & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • PGNY
  • Stock Information
  • Founded
  • OGN 1923
  • PGNY 2008
  • Country
  • OGN United States
  • PGNY United States
  • Employees
  • OGN N/A
  • PGNY N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • PGNY Misc Health and Biotechnology Services
  • Sector
  • OGN Health Care
  • PGNY Health Care
  • Exchange
  • OGN Nasdaq
  • PGNY Nasdaq
  • Market Cap
  • OGN 2.5B
  • PGNY 2.0B
  • IPO Year
  • OGN N/A
  • PGNY 2019
  • Fundamental
  • Price
  • OGN $9.52
  • PGNY $22.04
  • Analyst Decision
  • OGN Hold
  • PGNY Buy
  • Analyst Count
  • OGN 4
  • PGNY 8
  • Target Price
  • OGN $18.00
  • PGNY $24.00
  • AVG Volume (30 Days)
  • OGN 3.5M
  • PGNY 1.2M
  • Earning Date
  • OGN 08-05-2025
  • PGNY 08-07-2025
  • Dividend Yield
  • OGN 0.85%
  • PGNY N/A
  • EPS Growth
  • OGN N/A
  • PGNY N/A
  • EPS
  • OGN 2.88
  • PGNY 0.57
  • Revenue
  • OGN $6,294,000,000.00
  • PGNY $1,213,181,000.00
  • Revenue This Year
  • OGN N/A
  • PGNY $7.09
  • Revenue Next Year
  • OGN $1.11
  • PGNY $11.68
  • P/E Ratio
  • OGN $3.29
  • PGNY $38.82
  • Revenue Growth
  • OGN N/A
  • PGNY 9.46
  • 52 Week Low
  • OGN $8.01
  • PGNY $13.39
  • 52 Week High
  • OGN $23.10
  • PGNY $29.78
  • Technical
  • Relative Strength Index (RSI)
  • OGN 44.17
  • PGNY 52.84
  • Support Level
  • OGN $9.53
  • PGNY $22.60
  • Resistance Level
  • OGN $10.27
  • PGNY $23.60
  • Average True Range (ATR)
  • OGN 0.34
  • PGNY 0.85
  • MACD
  • OGN -0.04
  • PGNY 0.04
  • Stochastic Oscillator
  • OGN 5.49
  • PGNY 44.68

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About PGNY Progyny Inc.

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Share on Social Networks: